Federated Hermes’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $74.3K | Buy |
4,278
+3,860
| +923% | +$73.1K | ﹤0.01% | 1634 |
|
|
2025
Q4 | $7.88K | Buy |
+418
| New | +$7K | ﹤0.01% | 1855 |
|
|
2025
Q3 | – | Sell |
-113,950
| Closed | -$2.23M | – | 2132 |
|
|
2025
Q2 | $2.23M | Sell |
113,950
-17,911
| -14% | -$318K | ﹤0.01% | 916 |
|
|
2025
Q1 | $2.34M | Buy |
131,861
+30,284
| +30% | +$652K | 0.01% | 899 |
|
|
2024
Q4 | $2.17M | Buy |
101,577
+65,663
| +183% | +$1.6M | ﹤0.01% | 910 |
|
|
2024
Q3 | $1.12M | Sell |
35,914
-1,089
| -3% | -$27.1K | ﹤0.01% | 1080 |
|
|
2024
Q2 | $575K | Buy |
37,003
+2,536
| +7% | +$30.7K | ﹤0.01% | 1281 |
|
|
2024
Q1 | $365K | Buy |
34,467
+6,145
| +22% | +$61.5K | ﹤0.01% | 1389 |
|
|
2023
Q4 | $340K | Sell |
28,322
-4,805
| -15% | -$39.4K | ﹤0.01% | 1424 |
|
|
2023
Q3 | $232K | Sell |
33,127
-27,998
| -46% | -$259K | ﹤0.01% | 1506 |
|
|
2023
Q2 | $520K | Sell |
61,125
-99,379
| -62% | -$829K | ﹤0.01% | 1357 |
|
|
2023
Q1 | $1.47M | Buy |
160,504
+77,110
| +92% | +$986K | ﹤0.01% | 1056 |
|
|
2022
Q4 | $952K | Sell |
83,394
-158,781
| -66% | -$2.35M | ﹤0.01% | 1148 |
|
|
2022
Q3 | $4.12M | Buy |
242,175
+201,183
| +491% | +$4.32M | 0.01% | 713 |
|
|
2022
Q2 | $881K | Buy |
+40,992
| New | +$1.14M | ﹤0.01% | 1190 |
|
|
2021
Q3 | – | Sell |
-20,675
| Closed | -$1.89M | – | 2226 |
|
|
2021
Q2 | $1.89M | Sell |
20,675
-23,006
| -53% | -$1.83M | ﹤0.01% | 1120 |
|
|
2021
Q1 | $2.97M | Sell |
43,681
-130,312
| -75% | -$10.1M | 0.01% | 994 |
|
|
2020
Q4 | $12.6M | Buy |
173,993
+173,978
| +1,159,853% | +$10.1M | 0.03% | 583 |
|
|
2020
Q3 | $1K | Buy |
15
+6
| +67% | +$203 | ﹤0.01% | 2142 |
|
|
2020
Q2 | $1K | Buy |
+9
| New | +$256 | ﹤0.01% | 2131 |
|
|
2019
Q3 | – | Sell |
-316
| Closed | -$11K | – | 2211 |
|
|
2019
Q2 | $11K | Sell |
316
-240,058
| -100% | -$7.68M | ﹤0.01% | 1887 |
|
|
2019
Q1 | $7.58M | Buy |
240,374
+59,119
| +33% | +$1.72M | 0.02% | 664 |
|
|
2018
Q4 | $4.56M | Buy |
181,255
+168,898
| +1,367% | +$4.34M | 0.01% | 760 |
|
|
2018
Q3 | $356K | Buy |
12,357
+12,079
| +4,345% | +$226K | ﹤0.01% | 1529 |
|
|
2018
Q2 | $3K | Buy |
+278
| New | +$3.19K | ﹤0.01% | 2068 |
|
|
2015
Q2 | – | Sell |
-139,602
| Closed | -$774K | – | 1969 |
|
|
2015
Q1 | $774K | Sell |
139,602
-1,998
| -1% | -$13.2K | ﹤0.01% | 1252 |
|
|
2014
Q4 | $1.03M | Sell |
141,600
-158,400
| -53% | -$1.06M | ﹤0.01% | 1182 |
|
|
2014
Q3 | $2.1M | Buy |
+300,000
| New | +$2.88M | 0.01% | 955 |
|
Other funds holding CDNA
AIM
DM
B
VCM
GS
Federated Hermes's CDNA Position: Q1 2026 in Review
Federated Hermes increased its CareDx (CDNA) stake by 923% in Q1 2026, buying an estimated $73.1K and bringing the position to 4,278 shares worth $74.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1634.
Federated Hermes first reported a position in CDNA in Q3 2014 and has held it in 28 quarters since. The position peaked at $12.6M in Q4 2020. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.
- Federated Hermes held 4,278 shares of CareDx worth $74.3K as of Q1 2026.
- Federated Hermes bought 3,860 CareDx shares in Q1 2026, an estimated $73.1K.
- CareDx made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1634 holding.
- Federated Hermes first reported a position in CareDx in Q3 2014 and has held it in 28 quarters since.
- Federated Hermes's CareDx position peaked at $12.6M in Q4 2020.
- 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.